ANTISENSE COMPOUNDS TARGETING LEUCINE-RICH REPEAT KINASE 2 (LRRK2) FOR THE TREATMENT OF… Application WO-2019118325-A1 World Intellectual Property Organisation (WIPO) 20 Jun 2019